Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Antibody effector function and T cell reponses to homologous and heterologous inactivated or mRNA vaccines against SARS-CoV-2 Proceeding/Conference:Correlates of Protection for Next Generation Influenza Vaccines: Lessons learned from the COVID pandemic (01/03/2023-03/03/2023, Seattle) | 3-Mar-2023 | ||
Homologous and heterologous boosting with third-dose BNT162b2 and CoronaVac: a randomized trial (Cobovax study) Proceeding/Conference:Options for the Control of Influenza XI | 2022 |